Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robain

Showing results (221-230 of 233) with videos related to

Pageof 24
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 21, 2016
Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational studyS Delaloge, D Pérol, C Courtinard, et al.
BMJ Open|February 24, 2019
The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)David Pérol, Mathieu Robain, Patrick Arveux, et al.
Breast (Edinburgh, Scotland)|December 11, 2020
Impact of body mass index on overall survival in patients with metastatic breast cancerKhalil Saleh, Matthieu Carton, Véronique Dieras, et al.
British Journal of Cancer|November 14, 2019
Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohortAmélie Darlix, Guillaume Louvel, Julien Fraisse, et al.
Anticancer Research|July 5, 2020
Real-world Evaluation of Oral Vinorelbine in the Treatment of Metastatic Breast Cancer: An ESME-MBC StudyPierre Heudel, Suzette Delaloge, Damien Parent, et al.
ESMO Open|April 25, 2021
Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohortT Grinda, A Antoine, W Jacot, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2018
Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohortElisa Gobbini, Monia Ezzalfani, Véronique Dieras, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 4, 2018
[Antibiotic prophylaxis in urodynamics: Clinical practice guidelines using a formal consensus method]C Egrot, A Dinh, G Amarenco, et al.
European Journal of Cancer (Oxford, England : 1990)|March 6, 2020
Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016Elise Deluche, Alison Antoine, Thomas Bachelot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 14, 2020
Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysisElvire Pons-Tostivint, Youlia Kirova, Amélie Lusque, et al.
Pageof 24

Showing results (221-230 of 233) with videos related to

Sort By:
Pageof 24
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 21, 2016
Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational studyS Delaloge, D Pérol, C Courtinard, et al.
BMJ Open|February 24, 2019
The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)David Pérol, Mathieu Robain, Patrick Arveux, et al.
Breast (Edinburgh, Scotland)|December 11, 2020
Impact of body mass index on overall survival in patients with metastatic breast cancerKhalil Saleh, Matthieu Carton, Véronique Dieras, et al.
British Journal of Cancer|November 14, 2019
Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohortAmélie Darlix, Guillaume Louvel, Julien Fraisse, et al.
Anticancer Research|July 5, 2020
Real-world Evaluation of Oral Vinorelbine in the Treatment of Metastatic Breast Cancer: An ESME-MBC StudyPierre Heudel, Suzette Delaloge, Damien Parent, et al.
ESMO Open|April 25, 2021
Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohortT Grinda, A Antoine, W Jacot, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2018
Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohortElisa Gobbini, Monia Ezzalfani, Véronique Dieras, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 4, 2018
[Antibiotic prophylaxis in urodynamics: Clinical practice guidelines using a formal consensus method]C Egrot, A Dinh, G Amarenco, et al.
European Journal of Cancer (Oxford, England : 1990)|March 6, 2020
Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016Elise Deluche, Alison Antoine, Thomas Bachelot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 14, 2020
Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysisElvire Pons-Tostivint, Youlia Kirova, Amélie Lusque, et al.
Pageof 24